Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,482 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A monoclonal antibody against GPNMB.
Zhang P, Li J, Pang X, Yuan X, Li D, Li Y, Guo L, Liu W. Zhang P, et al. Among authors: pang x. Monoclon Antib Immunodiagn Immunother. 2013 Aug;32(4):265-9. doi: 10.1089/mab.2013.0005. Monoclon Antib Immunodiagn Immunother. 2013. PMID: 23909420
Reticular Erythema and Hyperpigmentation in a Woman.
Gu W, Shi D, Pang X, Shi F, Liu W. Gu W, et al. Among authors: pang x. J Cutan Med Surg. 2017 Sep/Oct;21(5):440. doi: 10.1177/1203475417711113. J Cutan Med Surg. 2017. PMID: 28920479 No abstract available.
A multicenter, randomized, double-blinded, placebo-controlled, phase Ⅲ study evaluating the efficacy and safety of Xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis.
Cai L, Jiang C, Zhang G, Fang H, Wang J, Li Y, Xu H, Xiao R, Ding Y, Huang K, Zhang C, Zhang L, Chen B, Duan X, Pan W, Han G, Chen R, Liu L, Zhang S, Tao J, Pang X, Yu J, Wang H, Zhao Y, Li C, Kang X, Qin L, Zhu X, Su J, Li S, Yang C, Feng W, Lei T, Jiang S, Fang R, Lin M, Lu Q, Xu C, Wang W, Zhang J. Cai L, et al. Among authors: pang x. Br J Dermatol. 2024 Feb 15:ljae062. doi: 10.1093/bjd/ljae062. Online ahead of print. Br J Dermatol. 2024. PMID: 38366639
A randomized, double-blind phase III study to demonstrate the clinical similarity of biosimilar SCT630 to reference adalimumab in Chinese patients with moderate to severe plaque psoriasis.
Yu C, Zhang F, Ding Y, Li Y, Zhao Y, Gu J, Guo S, Pan W, Jin H, Sun Q, Kang X, Yang Q, Jiang X, Song Z, Lu Q, Pang X, Kuang Y, Deng D, Li Y, Zhang C, Tao J, Xie L, Wang Y, Wang J, Wang G. Yu C, et al. Among authors: pang x. Int Immunopharmacol. 2022 Nov;112:109248. doi: 10.1016/j.intimp.2022.109248. Epub 2022 Sep 18. Int Immunopharmacol. 2022. PMID: 36126411 Clinical Trial.
Correction: Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study.
Wu Y, Fang F, Lai W, Li C, Li L, Liu Q, Lu J, Pang X, Sun J, Shi X, Picaut P, Prygova I, Andriopoulos B, Sun Q. Wu Y, et al. Among authors: pang x. Aesthetic Plast Surg. 2023 Jun;47(3):1243. doi: 10.1007/s00266-023-03306-1. Aesthetic Plast Surg. 2023. PMID: 36951993 Free PMC article. No abstract available.
Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study.
Wu Y, Fang F, Lai W, Li C, Li L, Liu Q, Lu J, Pang X, Sun J, Shi X, Picaut P, Prygova I, Andriopoulos B, Sun Q. Wu Y, et al. Among authors: pang x. Aesthetic Plast Surg. 2023 Feb;47(1):351-364. doi: 10.1007/s00266-022-03164-3. Epub 2022 Dec 19. Aesthetic Plast Surg. 2023. PMID: 36536093 Free PMC article. Clinical Trial.
3,482 results